Bernard Coulie
Chief Executive Officer bij PLIANT THERAPEUTICS, INC.
Vermogen: 13 M $ op 31-03-2024
Actieve functies van Bernard Coulie
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
PLIANT THERAPEUTICS, INC. | Director/Board Member | 01-02-2016 | - |
Chief Executive Officer | 01-02-2016 | - | |
President | 01-02-2016 | - | |
SQZ BIOTECHNOLOGIES COMPANY | Director/Board Member | 01-07-2021 | - |
Independent Dir/Board Member | 01-07-2021 | - | |
Calypso Biotech BV
Calypso Biotech BV BiotechnologyHealth Technology Calypso Biotech BV operates as immunotherapy biotech company. It develops monoclonal antibodies for the treatment of immune pathologies with large unmet medical needs. The company was founded by Alain Vicari and Yolande Chvatchko in 2013 and is headquartered in Amsterdam, the Netherlands. | Chairman | - | - |
Independent Dir/Board Member | - | - | |
Strebo Services Srl
Strebo Services Srl Medical/Nursing ServicesHealth Services Strebo Services Srl operates rest and care homes. The private company is based in La Louvière, Belgium. The Belgian company was founded in 2008. The CEO is Stéphane Mercier. | Director/Board Member | 01-01-2022 | - |
Dualyx NV
Dualyx NV Miscellaneous Commercial ServicesCommercial Services Dualyx NV is a biotech company based in Ghent, Belgium that focuses on developing novel Treg-based therapies for patients with difficult-to-treat autoimmune diseases. The CEO of the company is Wouter Verhoeven, and it is located in Zwijnaarde, Belgium. Dualyx has developed a pipeline of highly promising immune modulating programs, including DT-001, an antibody agonist program targeting the TNF receptor 2 (TNFR2), which is currently in IND-enabling studies. The Belgian company aims to create next-generation biologic drugs for autoimmunity therapies with novel mechanisms of action, lower toxicity, and improved patient outcomes than traditional therapeutics. The company was founded in 2020 by Luc van Rompaey in collaboration with Wurzburg University, Argenx, VIB, Ghent University, and KU Leuven. | Chairman | - | - |
Independent Dir/Board Member | - | - | |
Charcot-Marie-Tooth Association
Charcot-Marie-Tooth Association Miscellaneous Commercial ServicesCommercial Services The Charcot-Marie-Tooth Association operates as a non-profit organization. The private company is based in Glenolden, PA. Suzanne Louise Bruhn has been the CEO of the company since 2023. | Director/Board Member | - | - |
Independent Dir/Board Member | - | - |
Loopbaan van Bernard Coulie
Eerdere bekende functies van Bernard Coulie
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Pacira CryoTech, Inc.
Pacira CryoTech, Inc. Medical/Nursing ServicesHealth Services Pacira Cryotech, Inc. develops novel technologies for treatment of peripheral nerves. Its iovera treatment harnesses the power of cold with the Focused Cold Therapy delivery system and delivers immediate results for both therapeutic and aesthetic applications. The firm’s iovera treatment does not use toxins, chemicals, or pharmaceuticals to achieve results and leaves nothing behind in the body. The company was founded by Lisa Elkins in 2005 and is headquartered in Fremont, CA. | Director/Board Member | 01-06-2016 | 01-03-2019 |
Independent Dir/Board Member | 01-06-2016 | 01-03-2019 | |
Biogazelle NV
Biogazelle NV BiotechnologyHealth Technology Biogazelle NV is a research and development stage biotechnology firm. It specializes in ribonucleic acid for next generation diagnostics in the field of oncology and other diseases. The company was founded by Jan Hellemans and Jo Vandesompele in 2007 and is headquartered in Zwijnaarde, Belgium. | Director/Board Member | 01-07-2015 | 01-11-2018 |
Independent Dir/Board Member | 01-07-2015 | 01-11-2018 | |
Intrexon ActoBiotics NV
Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Director/Board Member | 01-06-2006 | 01-02-2015 |
Chief Executive Officer | 01-06-2006 | 01-02-2015 | |
Chief Tech/Sci/R&D Officer | 01-06-2006 | 01-02-2015 | |
Founder | 01-06-2006 | 01-02-2015 | |
░░░ ░░░░ ░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Opleiding van Bernard Coulie
Vlerick Leuven Gent Management School | Masters Business Admin |
Université Catholique de Louvain | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 7 |
België | 7 |
Nederland | 2 |
Operationeel
Director/Board Member | 7 |
Independent Dir/Board Member | 6 |
Chief Executive Officer | 2 |
Sectoraal
Health Technology | 7 |
Health Services | 4 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
JOHNSON & JOHNSON | Health Technology |
SQZ BIOTECHNOLOGIES COMPANY | Health Technology |
PLIANT THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 8 |
---|---|
Pacira CryoTech, Inc.
Pacira CryoTech, Inc. Medical/Nursing ServicesHealth Services Pacira Cryotech, Inc. develops novel technologies for treatment of peripheral nerves. Its iovera treatment harnesses the power of cold with the Focused Cold Therapy delivery system and delivers immediate results for both therapeutic and aesthetic applications. The firm’s iovera treatment does not use toxins, chemicals, or pharmaceuticals to achieve results and leaves nothing behind in the body. The company was founded by Lisa Elkins in 2005 and is headquartered in Fremont, CA. | Health Services |
The Mayo Clinic (Old)
The Mayo Clinic (Old) Hospital/Nursing ManagementHealth Services Mayo Clinic provided medical care. The firm offered healthy living program, mayo clinic membership and health letter, medical products, population health and wellness programs, health plan administration, medical laboratory services and continuing education for medical professionals. The company was founded by William J. Mayo in 1919 and was headquartered in Rochester, MN. | Health Services |
Intrexon ActoBiotics NV
Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Health Technology |
Biogazelle NV
Biogazelle NV BiotechnologyHealth Technology Biogazelle NV is a research and development stage biotechnology firm. It specializes in ribonucleic acid for next generation diagnostics in the field of oncology and other diseases. The company was founded by Jan Hellemans and Jo Vandesompele in 2007 and is headquartered in Zwijnaarde, Belgium. | Health Technology |
Calypso Biotech BV
Calypso Biotech BV BiotechnologyHealth Technology Calypso Biotech BV operates as immunotherapy biotech company. It develops monoclonal antibodies for the treatment of immune pathologies with large unmet medical needs. The company was founded by Alain Vicari and Yolande Chvatchko in 2013 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
Dualyx NV
Dualyx NV Miscellaneous Commercial ServicesCommercial Services Dualyx NV is a biotech company based in Ghent, Belgium that focuses on developing novel Treg-based therapies for patients with difficult-to-treat autoimmune diseases. The CEO of the company is Wouter Verhoeven, and it is located in Zwijnaarde, Belgium. Dualyx has developed a pipeline of highly promising immune modulating programs, including DT-001, an antibody agonist program targeting the TNF receptor 2 (TNFR2), which is currently in IND-enabling studies. The Belgian company aims to create next-generation biologic drugs for autoimmunity therapies with novel mechanisms of action, lower toxicity, and improved patient outcomes than traditional therapeutics. The company was founded in 2020 by Luc van Rompaey in collaboration with Wurzburg University, Argenx, VIB, Ghent University, and KU Leuven. | Commercial Services |
Strebo Services Srl
Strebo Services Srl Medical/Nursing ServicesHealth Services Strebo Services Srl operates rest and care homes. The private company is based in La Louvière, Belgium. The Belgian company was founded in 2008. The CEO is Stéphane Mercier. | Health Services |
Charcot-Marie-Tooth Association
Charcot-Marie-Tooth Association Miscellaneous Commercial ServicesCommercial Services The Charcot-Marie-Tooth Association operates as a non-profit organization. The private company is based in Glenolden, PA. Suzanne Louise Bruhn has been the CEO of the company since 2023. | Commercial Services |
- Beurs
- Insiders
- Bernard Coulie
- Ervaring